Ceftriaxone

Ceftriaxone Sodium and Sulbactam Sodium is a synergistic parenteral bactericidal formulation. Ceftriaxone provides broad-spectrum third-generation cephalosporin bactericidal action with a prolonged half-life, while sulbactam irreversibly inhibits beta-lactamases, overcoming resistance in ESBL-producing enterobacteriaceae and Acinetobacter. Indicated for severe community- and hospital-acquired pneumonia, sepsis, complicated intra-abdominal infections, pyelonephritis, and surgical prophylaxis.

Ceftriaxone Sodium and Tazobactam Sodium combines an extended-spectrum third-generation cephalosporin with the potent beta-lactamase inhibitor tazobactam. Tazobactam prevents ceftriaxone hydrolysis by plasmid- and chromosome-mediated beta-lactamases, restoring full bactericidal activity. Indicated for severe polymicrobial infections, meningitis, sepsis, complicated skin/soft tissue infections, and hospital-acquired lower respiratory infections.

Ceftriaxone Sodium and Sulbactam Sodium is a synergistic parenteral bactericidal formulation. Ceftriaxone provides broad-spectrum third-generation cephalosporin bactericidal action with a prolonged half-life, while sulbactam irreversibly inhibits beta-lactamases, overcoming resistance in ESBL-producing enterobacteriaceae and Acinetobacter. Indicated for severe community- and hospital-acquired pneumonia, sepsis, complicated intra-abdominal infections, pyelonephritis, and surgical prophylaxis.

Ceftriaxone Sodium and Sulbactam Sodium is a synergistic parenteral bactericidal formulation. Ceftriaxone provides broad-spectrum third-generation cephalosporin bactericidal action with a prolonged half-life, while sulbactam irreversibly inhibits beta-lactamases, overcoming resistance in ESBL-producing enterobacteriaceae and Acinetobacter. Indicated for severe community- and hospital-acquired pneumonia, sepsis, complicated intra-abdominal infections, pyelonephritis, and surgical prophylaxis.

Ceftriaxone Sodium is an essential third-generation parenteral cephalosporin bactericidal antibiotic on the WHO Model List of Essential Medicines. It features an exceptionally long elimination half-life (around 8 hours), permitting once-daily administration. Crosses the blood-brain barrier effectively. Indicated for bacterial meningitis, septicemia, community-acquired pneumonia, typhoid fever, complicated UTIs, gonococcal infections, pelvic inflammatory disease, and pre-operative surgical prophylaxis.

Ceftriaxone Sodium is an essential third-generation parenteral cephalosporin bactericidal antibiotic on the WHO Model List of Essential Medicines. It features an exceptionally long elimination half-life (around 8 hours), permitting once-daily administration. Crosses the blood-brain barrier effectively. Indicated for bacterial meningitis, septicemia, community-acquired pneumonia, typhoid fever, complicated UTIs, gonococcal infections, pelvic inflammatory disease, and pre-operative surgical prophylaxis.

Ceftriaxone Sodium is an essential third-generation parenteral cephalosporin bactericidal antibiotic on the WHO Model List of Essential Medicines. It features an exceptionally long elimination half-life (around 8 hours), permitting once-daily administration. Crosses the blood-brain barrier effectively. Indicated for bacterial meningitis, septicemia, community-acquired pneumonia, typhoid fever, complicated UTIs, gonococcal infections, pelvic inflammatory disease, and pre-operative surgical prophylaxis.

Ceftriaxone Sodium and Tazobactam Sodium combines an extended-spectrum third-generation cephalosporin with the potent beta-lactamase inhibitor tazobactam. Tazobactam prevents ceftriaxone hydrolysis by plasmid- and chromosome-mediated beta-lactamases, restoring full bactericidal activity. Indicated for severe polymicrobial infections, meningitis, sepsis, complicated skin/soft tissue infections, and hospital-acquired lower respiratory infections.

Ceftriaxone Sodium is an essential third-generation parenteral cephalosporin bactericidal antibiotic on the WHO Model List of Essential Medicines. It features an exceptionally long elimination half-life (around 8 hours), permitting once-daily administration. Crosses the blood-brain barrier effectively. Indicated for bacterial meningitis, septicemia, community-acquired pneumonia, typhoid fever, complicated UTIs, gonococcal infections, pelvic inflammatory disease, and pre-operative surgical prophylaxis.